Over the years, one of the most gratifying aspects of our monthly networking events has been learning about new San Antonio-based companies and meeting the visionary entrepreneurs behind them. San Antonians are justly proud of our city’s reputation for innovation and leadership in the healthcare industry so occasionally we like to highlight and celebrate these companies. This month, we shine our spotlight on MR3 Health.
MR3 Health is an innovative remote patient monitoring company focused on preventing the costly and life-altering complications associated with the foot ulcers associated with diabetic neuropathy. And, as most of us are aware, both the San Antonio and South Texas population in general have an unusually high prevalence of diabetes. The company integrates advanced medical devices, daily monitoring protocols and clinical oversight to identify early physiologic changes before they can escalate into acute events.
The company’s flagship monitoring device, TempTouch™, was likewise developed here in San Antonio by a distinguished group of local clinicians and engineers. An FDA-cleared dermal thermometer, the efficacy of the device was clinically proven in the field in partnership with the Veterans Health System and additional researchers associated with the University of Texas at San Antonio Health Science Center. Results of the clinical trials were documented in three peer-reviewed journal articles available on the company’s website. The company possesses proprietary patient management software and maintains a number of strategic industry partnerships that position it, according to MR3 president, Stan Marrett, as a credible and scalable partner for podiatrists, physician practices and health systems.
Given the ongoing prevalence of diabetes, the toll in human suffering in terms of repeated surgeries and amputations, and the staggering medical costs, estimated to be in the billions, that could be prevented by preventive monitoring for the range of chronic conditions including, not only diabetes, but hypertension and COPD as well, MR3’s business model and mission align closely with national public health priorities.
Another example of a San Antonio company helping people while setting the pace for its competition.




management of concerns outside of the primary care physician’s scope of practice. A simple phone call once served as an introductory transfer of the patient from primary to specialty care. Progress notes and polite thank you notes followed upon returning the patient to the primary care setting. Today, insurance regulations and paperwork have become the primary focus, while the actual diagnosis and treatment of the condition(s) have become a distant secondary focus. Medicare starts something and commercial insurers follow their lead, whether the policy is beneficial or harmful to their beneficiaries.







